Going beyond creating
our own products.
Pioneering Breakthroughs:
Marcyrl's Mission to Transform
Healthcare Across Continents
At Marcyrl, our mission is to be a beacon of hope and healing across continents, pioneering breakthroughs in pharmaceutical innovation and accessibility. Since our inception in 1996 as Marcyrl Import & Export Company, we have evolved into one of the Leading Global Pharmaceutical Companies, steadfastly committed to delivering cost-effective critical solutions to healthcare practitioners and their patients across Africa and the GCC region. Our journey is marked by milestones of excellence and dedication, from the establishment of our first manufacturing facility in 2003 under-license agreements with multinational corporations to the expansion of our production capabilities in 2013, catalyzing a new era of growth and innovation.
Charting a Path Towards Excellence:
Marcyrl's Vision for a Brighter
Future in Healthcare
Our vision at Marcyrl is to redefine the landscape of healthcare by continuously pushing the boundaries of possibility and compassion. As we embark on a journey towards a new facility for expansion in 2021, we envision a future where our EU GMP–certified manufacturing facilities serve as bastions of hope, producing innovative diversified specialty care treatments that address critical healthcare needs in different therapeutic areas, With a strong presence covering Africa and the GCC, we aspire to lead the way in delivering cost-effective critical solutions to healthcare practitioners to deliver optimal care to their patients, fostering healthier communities and a brighter tomorrow.
Excellence
We uphold a steadfast commitment to excellence in everything we do, striving for perfection in our research, development, manufacturing, and distribution processes to ensure the highest quality and efficacy of our products.

Innovation and Quality: "We are dedicated to pioneering innovations and maintaining unparalleled quality in all our endeavors, from research and development to manufacturing and distribution, ensuring superior efficacy in our products."

Excellence and Integrity: "Our unwavering commitment to excellence and integrity drives us to achieve perfection in our research, development, manufacturing, and distribution, delivering products of the highest quality and effectiveness."

Patient-Centered Care: "We strive for perfection in every aspect of our work, from research and development to manufacturing and distribution, ensuring our products meet the highest standards of quality and efficacy for the well-being of our patients."

Sustainability and Responsibility: "Our steadfast commitment to sustainability and responsibility guides us in every process, from research and development to manufacturing and distribution, ensuring the highest quality and efficacy of our products while caring for the environment and society."

Collaboration and Progress: "We uphold a steadfast commitment to collaboration and progress, striving for excellence in research, development, manufacturing, and distribution processes to ensure our products meet the highest standards of quality and efficacy."
The Board Members
Marcyrl has visionary minds behind our mission. Our board members bring expertise, passion, and leadership
to guide us toward a brighter future. Together, we lead the way for innovation

Mr Farid Habib
Founders

Dr Saad Ibrahim
Founders

Dr Wagdy Mounir
Founders

Dr George Saad
Managing directors and board members

Dr Micheal Wagdy
Managing directors and board members

Dr Mina Wagdy
Managing directors and board members
Investors
Impressed by Marcyrl’s solid performance and strong management team, Africa- focused private
equity funds DPI and Amethis announced their investment in Marcyrl in 2023

Amethis is an investment fund manager dedicated to Africa and Europe, with an investment capacity exceeding €1.1bn. Amethis brings growth capital to promising midcap champions in a diversity of sectors throughout the African and European continents.As an active shareholder, Amethis offers key support and expertise through its international network, its opportunities of external growth, and its value-added governance.

DPI was founded in 2007 on the vision of building a premier investment firm with excellence at its core. We wanted to back exceptional businesses to allow African entrepreneurs and CEOs to achieve their ambitions, while striving to deliver top-quartile returns and positive impact for Africa.
What would you like to
contact us about?
Get in touch
Get in touch
Get in touch
Get in touch
Facilities
Collaboration
Why partner with us
How we could work together
Therapeutic areas
Alimentary & Metabolism
Blood & Blood Forming Organs
Cardiovascular
Dermatological
Genital & urinary systems & Sex Hormones
Systemic Hormones
Systemic Anti-infectives
Hospital Solutions
Antineoplastic & Immunomodulators
Muscu-skeletal system
Nervous system
Parasitology
Respiratory
Sensory organs
Diagnostic
Various
Head Office
Tel
(202)22678596
(202)22678597

Fax
(202)22660905

info@marcyrl.com

16 El Mosheer Ahmed Ismail St., Square 1160, Sheraton, Cairo, Egypt